Anticancer activity of green tea polyphenols in prostate gland

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Davalli, Pierpaola ^a   Rizzi, Federica ^b,c   Caporali, Andrea ^d   Pellacani, Davide ^e   Davoli, Serena ^f   Bettuzzi, Saverio ^b,c   Brausi, Maurizio ^g   D'Arca, Domenico ^a,c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF YORK   (United Kingdom)

^f INSERM   (France)

^g B Ramazzini Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANTICANCER ACTIVITIES; ANTICANCER EFFECTS; CANCER RISK; CHEMOPREVENTIVE; CONSERVATIVE MANAGEMENT; EPIDEMIOLOGICAL STUDIES; GREEN TEA POLYPHENOLS; HUMAN PROSTATE CANCER; PROSTATE CANCERS; PROSTATE GLANDS; QUALITY OF LIFE; TEA POLYPHENOLS; THERAPEUTIC INTERVENTION; TIME-PERIODS; TUMORIGENESIS; WESTERN COUNTRIES;

CELL CULTURE; DISEASES; PATIENT MONITORING; UROLOGY;

PHENOLS;

ANDROGEN RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLOOXYGENASE 2; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL; POLYPHENON E; PROSTATE SPECIFIC ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RESVERATROL; SOMATOMEDIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ANTINEOPLASTIC AGENT;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL CYCLE ARREST; CELL DEATH; CHEMOPROPHYLAXIS; CHROMATIN STRUCTURE; DNA METHYLATION; DRUG EFFICACY; DRUG METABOLISM; ENZYME ACTIVATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTRACELLULAR SIGNALING; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; OXIDATIVE STRESS; PROSTATE CANCER; REVIEW; SINGLE DRUG DOSE; TEA; TISSUE DISTRIBUTION; ANIMAL; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; GENETICS; MALE; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

ANIMALS; ANTICARCINOGENIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MALE; POLYPHENOLS; PROSTATE; PROSTATIC NEOPLASMS; TEA;

EID: 84862289573     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/984219     Document Type: Review

References (130)

1. Moyad M. A., Carroll P. R., Lifestyle recommendations to prevent prostate cancerpart I: time to redirect our attention? Urologic Clinics of North America 2004 31 2 289 300 (Pubitemid 38584594)
2. Namiki M., Akaza H., Lee S. E., Song J. M., Umbas R., Zhou L., Lee B. C., Cheng C., Chung M. K., Fukagai T., Hinotsu S., Horie S., Prostate cancer working group report Japanese Journal of Clinical Oncology 2010 40 1 i70 i75
3. DeWeese T. L., Hruszkewycz A. M., Marnett L. J., Oxidative stress in chemoprevention trials Urology 2001 57 4 137 140
4. Konishi N., Shimada K., Ishida E., Nakamura M., Molecular pathology of prostate cancer Pathology International 2005 55 9 531 539 (Pubitemid 41725526)
5. Nelson W. G., De Marzo A. M., DeWeese T. L., Isaacs W. B., Gelmann E. P., Rubin M. A., Nelson J. B., Klotz L., Kantoff P. W., Sandler H., The role of inflammation in the pathogenesis of prostate cancer Journal of Urology 2004 172 5 S6 S12
6. Minelli A., Bellezza I., Conte C., Culig Z., Oxidative stress-related aging: a role for prostate cancer? Biochimica et Biophysica Acta 2009 1795 2 83 91
7. Balentine D. A., Wiseman S. A., Bouwens L. C. M., The chemistry of tea flavonoids Critical Reviews in Food Science and Nutrition 1997 37 8 693 704 (Pubitemid 127349613)
8. Valcic S., Burr J. A., Timmermann B. N., Liebler D. C., Antioxidant chemistry of green tea catechins. New oxidation products of (-)-epigallocatechin gallate and (-)-epigallocatechin from their reactions with peroxyl radicals Chemical Research in Toxicology 2000 13 9 801 810
9. Sang S., Tian S., Meng X., Stark R. E., Rosen R. T., Yang C. S., Ho C. T., Theadibenzotropolone A, a new type pigment from enzymatic oxidation of (-)-epicatechin and (-)-epigallocatechin gallate and characterized from black tea using LC/MS/MS Tetrahedron Letters 2002 43 40 7129 7133
10. Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Advanced Drug Delivery Reviews 2001 46 13 3 26 (Pubitemid 33653411)
11. Mak J. C., the potential role of green tea catechins in various disease therapies: progress and promise Clinical and Experimental Pharmacology and Physiology 2012 39 3 265 273
12. Chen L., Zhang H. Y., Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate Molecules 2007 12 5 946 957
13. Adhami V. M., Ahmad N., Mukhtar H., Molecular targets for green tea in prostate cancer prevention Journal of Nutrition 2003 133 7 2417S 2424S (Pubitemid 36828848)
14. Johnson J. J., Bailey H. H., Mukhtar H., Green tea polyphenols for prostate cancer chemoprevention: a translational perspective Phytomedicine 2010 17 1 3 13
15. Khan N., Adhami V. M., Mukhtar H., Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies Nutrition and Cancer 2009 61 6 836 841
16. Siddiqui I. A., Saleem M., Adhami V. M., Asim M., Mukhtar H., Tea beverage in chemoprevention and chemotherapy of prostate cancer Acta Pharmacologica Sinica 2007 28 9 1392 1408 (Pubitemid 47366690)
17. Yang C. S., Wang H., Li G. X., Yang Z., Guan F., Jin H., Cancer prevention by tea: evidence from laboratory studies Pharmacological Research 2011 64 2 113 122
18. Gupta S., Ahmad N., Nieminen A. L., Mukhtar H., Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells Toxicology and Applied Pharmacology 2000 164 1 82 90 (Pubitemid 30198547)
19. Caporali A., Davalli P., Astancolle S., D'Arca D., Brausi M., Bettuzzi S., Corti A., The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression Carcinogenesis 2004 25 11 2217 2224 (Pubitemid 39534860)
20. Albrecht D. S., Clubbs E. A., Ferruzzi M., Bomser J. A., Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation Chemico-Biological Interactions 2008 171 1 89 95 (Pubitemid 350191843)
21. Ahmad N., Feyes D. K., Nieminen A. L., Agarwal R., Mukhtar H., Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells Journal of the National Cancer Institute 1997 89 24 1881 1886 (Pubitemid 28009824)
22. Gupta S., Hussain T., Mukhtar H., Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells Archives of Biochemistry and Biophysics 2003 410 1 177 185 (Pubitemid 36268810)
23. Hastak K., Gupta S., Ahmad N., Agarwal M. K., Agarwal M. L., Mukhtar H., Role of p53 and NF- B in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells Oncogene 2003 22 31 4851 4859 (Pubitemid 36981273)
24. Hastak K., Agarwal M. K., Mukhtar H., Agarwal M. L., Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate FASEB Journal 2005 19 7 789 791 (Pubitemid 40617385)
25. Siddiqui I. A., Malik A., Adhami V. M., Asim M., Hafeez B. B., Sarfaraz S., Mukhtar H., Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis Oncogene 2008 27 14 2055 2063 (Pubitemid 351442738)
26. Chung L. Y., Cheung T. C., Kong S. K., Fung K. P., Choy Y. M., Chan Z. Y., Kwok T. T., Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells Life Sciences 2001 68 10 1207 1214 (Pubitemid 32168047)
27. Nair S., Li W., Kong A. N. T., Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells Acta Pharmacologica Sinica 2007 28 4 459 472 (Pubitemid 46496089)
28. Na H. K., Surh Y. J., Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG Food and Chemical Toxicology 2008 46 4 1271 1278
29. Chen C., Yu R., Owuor E. D., Tony Kong A. N., Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death Archives of Pharmacal Research 2000 23 6 605 612
30. Nair S., Barve A., Khor T. O., Shen G. X., Lin W., Chan J. Y., Cai L., Kong A. N., Regulation of Nrf2-and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells Acta Pharmacologica Sinica 2010 31 9 1223 1240
31. Hussain T., Gupta S., Adhami V. M., Mukhtar H., Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells International Journal of Cancer 2005 113 4 660 669 (Pubitemid 40038745)
32. Adhami V. M., Malik A., Zaman N., Sarfaraz S., Siddiqui I. A., Syed D. N., Afaq F., Pasha F. S., Saleem M., Mukhtar H., Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo Clinical Cancer Research 2007 13 5 1611 1619 (Pubitemid 46450454)
33. Vayalil P. K., Katiyar S. K., Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF- B in human prostate carcinoma DU-145 cells Prostate 2004 59 1 33 42 (Pubitemid 38387841)
34. Li M., He Z., Ermakova S., Zheng D., Tang F., Cho Y. Y., Zhu F., Ma W. Y., Sham Y., Rogozin E. A., Bode A. M., Cao Y., Dong Z., Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3- gallate regulates cell transformation Cancer Epidemiology Biomarkers and Prevention 2007 16 3 598 605 (Pubitemid 46548666)
35. Thomas F., Patel S., Holly J. M. P., Persad R., Bahl A., Perks C. M., Dihydrotestosterone SEnsitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor Prostate 2009 69 2 219 224
36. Siddiqui I. A., Adhami V. M., Afaq F., Ahmad N., Mukhtar H., Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells Journal of Cellular Biochemistry 2004 91 2 232 242
37. Saraon P., Jarvi K., Diamandis E. P., Molecular alterations during progression of prostate cancer to androgen independence Clinical Chemistry 2011 57 1366 1375
38. Ryan C. J., Tindall D. J., Androgen receptor rediscovered: the new biology and targeting the androgen receptor therapeutically Journal of Clinical Oncology 2011 29 3651 3658
39. Basu S., Tindall D. J., Androgen action in prostate cancer Hormones and Cancer 2010 1 5 223 228
40. Friedrich M. J., Debate continues on use of PSA testing for early detection of prostate cancer Journal of the American Medical Association 2011 305 22 2273 2276
41. Siddiqui I. A., Asim M., Hafeez B. B., Adhami V. M., Tarapore R. S., Mukhtar H., Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer FASEB Journal 2011 25 4 1198 1207
42. Chuu C. P., Chen R. Y., Kokontis J. M., Hiipakka R. A., Liao S., Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells Cancer Letters 2009 275 1 86 92
43. Ren F., Zhang S., Mitchell S. H., Butler R., Young C. Y. F., Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells Oncogene 2000 19 15 1924 1932 (Pubitemid 30219035)
44. Pezzato E., Sartor L., Dell'Aica I., Dittadi R., Gion M., Belluco C., Lise M., Garbisa S., Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin- 3-gallate International Journal of Cancer 2004 112 5 787 792 (Pubitemid 39435263)
45. Siddiqui I. A., Zaman N., Aziz M. H., Reagan-Shaw S. R., Sarfaraz S., Adhami V. M., Ahmad N., Raisuddin S., Mukhtar H., Inhibition of CWR22R 1 tumor growth and PSA secretion in athymic nude mice by green and black teas Carcinogenesis 2006 27 4 833 839
46. Huss W. J., Maddison L. A., Greenberg N. M., Autochthonous mouse models for prostate cancer: past, present and future Seminars in Cancer Biology 2001 11 3 245 259 (Pubitemid 32619867)
47. Sartor L., Pezzato E., Don M., Dell'Aica I., Calabrese F., Morini M., Albini A., Garbisa S., Prostate carcinoma and green tea: (-)epigallocatechin-3- gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine tramp model International Journal of Cancer 2004 112 5 823 829 (Pubitemid 39435267)
48. Liao S., Umekita Y., Guo J., Kokontis J. M., Hiipakka R. A., Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate Cancer Letters 1995 96 2 239 243
49. Zhou J. R., Yu L., Zhong Y., Blackburn G. L., Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice Journal of Nutrition 2003 133 2 516 521 (Pubitemid 36172909)
50. Greenberg N. M., DeMayo F., Finegold M. J., Medina D., Tilley W. D., Aspinall J. O., Cunha G. R., Donjacour A. A., Matusik R. J., Rosen J. M., Prostate cancer in a transgenic mouse Proceedings of the National Academy of Sciences of the United States of America 1995 92 8 3439 3443
51. Dilworth S. M., Cell alterations induced by the large T-antigens of SV40 and polyoma virus Seminars in Cancer Biology 1990 1 6 407 414
52. Sontag E., Fedorov S., Kamibayashi C., Robbins D., Cobb M., Mumby M., The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation Cell 1993 75 5 887 897 (Pubitemid 24014546)
53. Gupta S., Hastak K., Ahmad N., Lewin J. S., Mukhtar H., Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols Proceedings of the National Academy of Sciences of the United States of America 2001 98 18 10350 10355 (Pubitemid 32803023)
54. Adhami V. M., Siddiqui I. A., Ahmad N., Gupta S., Mukhtar H., Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer Cancer Research 2004 64 23 8715 8722 (Pubitemid 39552088)
55. Kaplan P. J., Mohan S., Cohen P., Foster B. A., Greenberg N. M., The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model Cancer Research 1999 59 9 2203 2209 (Pubitemid 29217686)
56. Saleem M., Adhami V. M., Ahmad N., Gupta S., Mukhtar H., Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model Clinical Cancer Research 2005 11 1 147 153 (Pubitemid 40075789)
57. Siddiqui I. A., Shukla Y., Adhami V. M., Sarfaraz S., Asim M., Hafeez B. B., Mukhtar H., Suppression of NF B and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model Pharmaceutical Research 2008 25 9 2135 2142
58. Azzali G., Tumor cell transendothelial passage in the absorbing lymphatic vessel of transgenic adenocarcinoma mouse prostate American Journal of Pathology 2007 170 1 334 346 (Pubitemid 47339211)
59. McCarthy S., Caporali A., Enkemann S., Scaltriti M., Eschrich S., Davalli P., Corti A., Lee A., Sung J., Yeatman T. J., Bettuzzi S., Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer Molecular Oncology 2007 1 2 196 204 (Pubitemid 47199136)
60. Davalli P., Rizzi F., Caldara G. F., Chronic administration of green tea extract to TRAMP mice induces the collapse of Golgi apparatus in prostate secretory cells and results in alterations of protein post- translational processing Journal of Clinical Oncology 2011 39 1521 1527
61. Harper C. E., Patel B. B., Wang J., Eltoum I. A., Lamartiniere C. A., Epigallocatechin-3-gallate suppresses early stage, but not late stage prostate cancer inTRAMP mice: mechanisms of action Prostate 2007 67 14 1576 1589 (Pubitemid 47536156)
62. Adhami V. M., Siddiqui I. A., Sarfaraz S., Khwaja S. I., Hafeez B. B., Ahmad N., Mukhtar H., Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on Thestage of the disease Clinical Cancer Research 2009 15 6 1947 1953
63. Choan E., Segal R., Jonker D., Malone S., Reaume N., Eapen L., Gallant V., A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach Urologic Oncology 2005 23 2 108 113 (Pubitemid 40616301)
64. Jatoi A., Ellison N., Burch P. A., Sloan J. A., Dakhil S. R., Novotny P., Tan W., Fitch T. R., Rowland K. M., Young C. Y. F., Flynn P. J., A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma Cancer 2003 97 6 1442 1446 (Pubitemid 36297774)
65. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., Corti A., Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study Cancer Research 2006 66 2 1234 1240 (Pubitemid 43165995)
66. Brausi M., Rizzi F., Bettuzzi S., Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update European Urology 2008 54 2 472 473
67. Jemal A., Siegel R., Xu J., Ward E., Cancer statistics, 2010 CA Cancer Journal for Clinicians 2010 60 5 277 300
68. Bray F., Lortet-Tieulent J., Ferlay J., Forman D., Auvinen A., Prostate cancer incidence and mortality trends in 37 European countries: an overview European Journal of Cancer 2010 46 17 3040 3052
69. Studer U. E., Collette L., Prostate cancer: to screen or not to screen? Nature Reviews Urology 2009 6 6 299 301
70. Crawford E. D., Understanding the epidemiology, natural history, and key pathways involved in prostate cancer Urology 2009 73 5 S4 S10
71. Diamandis E. P., Early prostate cancer antigen-2: a controversial prostate cancer biomarker? Clinical Chemistry 2010 56 4 542 544
72. Shimizu H., Ross R. K., Bernstein L., Yatani R., Henderson B. E., Mack T. M., Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County British Journal of Cancer 1991 63 6 963 966
73. Haenszel W., Kurihara M., Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States Journal of the National Cancer Institute 1968 40 1 43 68
74. Zheng J., Yang B., Huang T., Yu Y., Yang J., Li D., Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies Nutrition and Cancer 2011 63 5 663 672
75. Severson R. K., Nomura A. M. Y., Grove J. S., Stemmermann G. N., A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii Cancer Research 1989 49 7 1857 1860 (Pubitemid 19108416)
76. Allen N. E., Sauvaget C., Roddam A. W., Appleby P., Nagano J., Suzuki G., Key T. J., Koyama K., A prospective study of diet and prostate cancer in Japanese men Cancer Causes and Control 2004 15 9 911 920 (Pubitemid 39663867)
77. Jian L., Xie L. P., Lee A. H., Binns C. W., Protective effect of green tea against prostate cancer: a case-control study in southeast China International Journal of Cancer 2004 108 1 130 135 (Pubitemid 37444455)
78. Sonoda T., Nagata Y., Mori M., Miyanaga N., Takashima N., Okumura K., Goto K., Naito S., Fujimoto K., Hirao Y., Takahashi A., Tsukamoto T., Fujioka T., Akaza H., A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet Cancer Science 2004 95 3 238 242 (Pubitemid 38489090)
79. Kikuchi N., Ohmori K., Shimazu T., Nakaya N., Kuriyama S., Nishino Y., Tsubono Y., Tsuji I., No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort study British Journal of Cancer 2006 95 3 371 373 (Pubitemid 44187600)
80. Kurahashi N., Sasazuki S., Iwasaki M., Inoue M., Green tea consumption and prostate cancer risk in Japanese men: a prospective study American Journal of Epidemiology 2008 167 1 71 77
81. Chow H. H. S., Cai Y., Alberts D. S., Hakim I., Dorr R., Shahi F., Crowell J. A., Yang C. S., Hara Y., Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and Polyphenon E Cancer Epidemiology Biomarkers and Prevention 2001 10 1 53 58 (Pubitemid 32106044)
82. Chow H. H. S., Cai Y., Hakim I. A., Crowell J. A., Shahi F., Brooks C. A., Dorr R. T., Hara Y., Alberts D. S., Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals Clinical Cancer Research 2003 9 9 3312 3319 (Pubitemid 37082725)
83. Chow H. H. S., Hakim I. A., Vining D. R., Crowell J. A., Ranger-Moore J., Chew W. M., Celaya C. A., Rodney S. R., Hara Y., Alberts D. S., Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals Clinical Cancer Research 2005 11 12 4627 4633 (Pubitemid 40825654)
84. Henning S. M., Aronson W., Niu Y., Conde F., Lee N. H., Seeram N. P., Lee R. P., Lu J., Harris D. M., Moro A., Hong J., Leung P. S., Barnard R. J., Ziaee H. G., Csathy G., Go V. L. W., Wang H., Heber D., Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption Journal of Nutrition 2006 136 7 1839 1843 (Pubitemid 43973585)
85. Nguyen M. M., Ahmann F. R., Nagle R. B., Randomized, double-blind, placebo controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities Cancer Prevention Research 2012 5 290 298
86. McLarty J., Bigelow R. L. H., Smith M., Elmajian D., Ankem M., Cardelli J. A., Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro Cancer Prevention Research 2009 2 7 673 682
87. Portela A., Esteller M., Epigenetic modifications and human disease Nature Biotechnology 2010 28 10 1057 1068
88. Jaenisch R., Bird A., Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals Nature Genetics 2003 33 245 254 (Pubitemid 36278835)
89. Feinberg A. P., Tycko B., The history of cancer epigenetics Nature Reviews Cancer 2004 4 2 143 153 (Pubitemid 38198742)
90. Fang M. Z., Wang Y., Ai N., Hou Z., Sun Y., Lu H., Welsh W., Yang C. S., Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines Cancer Research 2003 63 22 7563 7570 (Pubitemid 37466673)
91. Pandey M., Shukla S., Gupta S., Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells International Journal of Cancer 2010 126 11 2520 2533
92. Meiers I., Shanks J. H., Bostwick D. G., Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007 Pathology 2007 39 3 299 304 (Pubitemid 46897603)
93. Morey Kinney S. R., Zhang W., Pascual M., Greally J. M., Gillard B. M., Karasik E., Foster B. A., Karpf A. R., Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate Cancer Prevention Research 2009 2 12 1065 1075
94. Suzuki M., Greally J. M., DNA methylation profiling using HpaII tiny fragment enrichment by ligation-mediated PCR (HELP) Methods 2010 52 3 218 222
95. Navarro-Pern E., Cabezas-Herrera J., Campo L. S. D., Rodrguez-Lpez J. N., Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate International Journal of Biochemistry and Cell Biology 2007 39 12 2215 2225 (Pubitemid 47484276)
96. Zhu B. T., Patel U. K., Cai M. X., Conney A. H., O-methylation of tea polyphenols catalyzed by human placental cytosolic catechol-o-methyltransferase Drug Metabolism and Disposition 2000 28 9 1024 1030 (Pubitemid 30660355)
97. Lee W. J., Shim J. Y., Zhu B. T., Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids Molecular Pharmacology 2005 68 4 1018 1030 (Pubitemid 41345793)
98. Kornberg R. D., Lorch Y., Chromatin-modifying and -remodeling complexes Current Opinion in Genetics and Development 1999 9 2 148 151 (Pubitemid 29158547)
99. Kouzarides T., Chromatin Modifications and Their Function Cell 2007 128 4 693 705 (Pubitemid 46273577)
100. Turner B. M., Cellular memory and the histone code Cell 2002 111 3 285 291 (Pubitemid 35341385)
101. Rajendran P., Ho E., Williams D. E., Dashwood R. H., Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells Clinical Epigenetics 2011 3 1, article 4
102. Thakur V. S., Gupta K., Gupta S., Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases Carcinogenesis 2012 33 377 384
103. Zeng Y., Cullen B. R., Recognition and cleavage of primary microRNA transcripts Methods in Molecular Biology 2006 342 49 56
104. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function Cell 2004 116 2 281 297
105. Yi R., Qin Y., Macara I. G., Cullen B. R., Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs Genes and Development 2003 17 24 3011 3016 (Pubitemid 38040764)
106. He L., Hannon G. J., MicroRNAs: small RNAs with a big role in gene regulation Nature Reviews Genetics 2004 5 522 531 (Pubitemid 38868508)
107. Gregory R. I., Chendrimada T. P., Cooch N., Shiekhattar R., Human RISC couples microRNA biogenesis and posttranscriptional gene silencing Cell 2005 123 4 631 640 (Pubitemid 41608466)
108. Couzin J., MicroRNAs make big impression in disease after disease Science 2008 319 5871 1782 1784 (Pubitemid 351451552)
109. Ambs S., Prueitt R. L., Yi M., Hudson R. S., Howe T. M., Petrocca F., Wallace T. A., Liu C. G., Volinia S., Calin G. A., Yfantis H. G., Stephens R. M., Croce C. M., Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer Cancer Research 2008 68 15 6162 6170
110. Ozen M., Creighton C. J., Ozdemir M., Ittmann M., Widespread deregulation of microRNA expression in human prostate cancer Oncogene 2008 27 12 1788 1793 (Pubitemid 351380263)
111. Porkka K. P., Pfeiffer M. J., Waltering K. K., Vessella R. L., Tammela T. L. J., Visakorpi T., MicroRNA expression profiling in prostate cancer Cancer Research 2007 67 13 6130 6135 (Pubitemid 47037493)
112. Bonci D., Coppola V., Musumeci M., Addario A., Giuffrida R., Memeo L., D'Urso L., Pagliuca A., Biffoni M., Labbaye C., Bartucci M., Muto G., Peschle C., De Maria R., The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities Nature Medicine 2008 14 11 1271 1277
113. Varambally S., Cao Q., Mani R. S., Shankar S., Wang X., Ateeq B., Laxman B., Cao X., Jing X., Ramnarayanan K., Brenner J. C., Yu J., Kim J. H., Han B., Tan P., Kumar-Sinha C., Lonigro R. J., Palanisamy N., Maher C. A., Chinnaiyan A. M., Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer Science 2008 322 5908 1695 1699
114. Epis M. R., Giles K. M., Barker A., Kendrick T. S., Leedman P. J., miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer Journal of Biological Chemistry 2009 284 37 24696 24704
115. Noonan E. J., Place R. F., Pookot D., Basak S., Whitson J. M., Hirata H., Giardina C., Dahiya R., MiR-449a targets HDAC-1 and induces growth arrest in prostate cancer Oncogene 2009 28 14 1714 1724
116. Poliseno L., Salmena L., Riccardi L., Fornari A., Song M. S., Hobbs R. M., Sportoletti P., Varmeh S., Egia A., Fedele G., Rameh L., Loda M., Pandolfi P. P., Identification of the miR-106 b 25 microRNA cluster as a proto-oncogenic PTEN -targeting intron that cooperates with its host gene MCM7 in transformation Science Signaling 2010 3 117 ra29
117. Rokhlin O. W., Scheinker V. S., Taghiyev A. F., Bumcrot D., Glover R. A., Cohen M. B., MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer Cancer Biology and Therapy 2008 7 8 1288 1296
118. Lee K. H., Chen Y. L., Yeh S. D., Hsiao M., Lin J. T., Goan Y. G., Lu P. J., MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation Oncogene 2009 28 38 3360 3370
119. Ribas J., Ni X., Haffner M., Wentzel E. A., Salmasi A. H., Chowdhury W. H., Kudrolli T. A., Yegnasubramanian S., Luo J., Rodriguez R., Mendell J. T., Lupold S. E., miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth Cancer Research 2009 69 18 7165 7169
120. Sun T., Wang Q., Balk S., Brown M., Lee G. S. M., Kantoff P., The role of microrna-221 and microrna-222 in Androgen- independent prostate cancer cell lines Cancer Research 2009 69 8 3356 3363
121. Lin S. L., Chiang A., Chang D., Ying S. Y., Loss of mir-146a function in hormone-refractory prostate cancer RNA 2008 14 3 417 424 (Pubitemid 351397806)
122. Mitchell P. S., Parkin R. K., Kroh E. M., Fritz B. R., Wyman S. K., Pogosova-Agadjanyan E. L., Peterson A., Noteboom J., O'Briant K. C., Allen A., Lin D. W., Urban N., Drescher C. W., Knudsen B. S., Stirewalt D. L., Gentleman R., Vessella R. L., Nelson P. S., Martin D. B., Tewari M., Circulating microRNAs as stable blood-based markers for cancer detection Proceedings of the National Academy of Sciences of the United States of America 2008 105 30 10513 10518
123. Gonzales J. C., Fink L. M., Goodman O. B. Jr., Symanowski J. T., Vogelzang N. J., Ward D. C., Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer Clinical Genitourinary Cancer 2011 9 39 45
124. Selth L. A., Townley S., Gillis J. L., Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. International Journal of Cancer. In press
125. Schmid H. P., Fischer C., Engeler D. S., Bendhack M. L., Schmitz-Drger B. J., Nutritional aspects of primary prostate cancer prevention Recent Results in Cancer Research 2011 188 101 107
126. Scaltriti M., Belloni L., Caporali A., Davalli P., Remondini D., Rizzi F., Astancolle S., Corti A., Bettuzzi S., Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling Carcinogenesis 2006 27 5 1047 1053
127. Yang C. S., Wang X., Green tea and cancer prevention Nutrition and Cancer 2010 62 931 937
128. Bao B., Ali S., Banerjee S., Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression Cancer Research 2012 72 335 345
129. Majid S., Dar A. A., Saini S., Chen Y., Shahryari V., Liu J., Zaman M. S., Hirata H., Yamamura S., Ueno K., Tanaka Y., Dahiya R., Regulation of minichromosome maintenance gene family by MicroRNA-1296 and genistein in prostate cancer Cancer Research 2010 70 7 2809 2818
130. Dhar S., Hicks C., Levenson A. S., Resveratrol and prostate cancer: promising role for microRNAs Molecular Nutrition and Food Research 2011 55 8 1219 1229